openPR Logo
Press release

Non Hodgkins Lymphoma (NHL) Therapeutics Market Share and Growth Factors Impact Analysis 2014 – 2020

03-14-2018 10:46 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Non Hodgkins Lymphoma (NHL) Therapeutics Market Share

Lymphoma is one of the most hazardous and life threatening type of cancer, related to lymphocytes, an important type of white blood cells. Non-Hodgkin’s lymphomas (NHL) is a distinct group of blood cancer, which includes large variety of lymphomas, excluding Hodgkin’s lymphomas. Non-Hodgkin’s lymphoma (NHL) varies in their severity, from mild to fatal. According to a new classification of lymphomas published by WHO in 2008, the lymphomas are segmented into four different groups, instead of segregating as Hodgkin’s and Non-Hodgkin’s lymphomas. The list comprises of around 80 various types of lymphomas.

The major causes of Non-Hodgkin’s lymphomas (NHL) include chemical interaction, such as, interaction with diphenylhydantoin, polychlorinated biphenyls and other toxic compounds, autoimmune disorders, such as, rheumatoid arthritis, celiac sprue, Sjogren’s syndrome and others, medication and radiation therapy, infections, such as, H. pylori infection, HIV infection, hepatitis C viral infection, human T-cell leukemia virus, Epstein-Barr virus and others, genetic disorders such as ataxia telangiectasis syndrome, Klienfelter’s syndrome and others. Major symptoms of the disease includes night sweats, itchy skin, frequent high fever, breath shortness, loss of appetite and weight and painless sweating of lymph nodes present on various locations in the body.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2668

The market of Non-Hodgkin’s lymphomas (NHL) is segmented on the basis of phase of the disease (severity), such as, phase I, II, III, and IV. Further, the market is segmented on the basis of types of Non-Hodgkin’s lymphomas (NHL), such as, AIDS-related lymphomas, Mantel Cell lymphoma, cutaneous T-cell lymphoma, blastic NK-cell lymphoma, T-cell leukemia, Burkitt’s lymphoma, follicular lymphoma, Waldenstrom’s Macroglobulinemia and many others. Furthermore, the market is segmented on the basis of therapeutic agents, such as, chemotherapy, stem cell therapy, radiations, novel targeted target therapy and other. A large number of therapeutic agents are used to treat Non-Hodgkin’s lymphomas (NHL), such as methotrexate, bortezomib, cyclophosphamide, bleomycin, chlorambucil, liposomal cytarabine, nelarabine, doxorubicin hydrochloride and many others.

Moreover, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, North America and Europe are the most prominent markets, owing to extensive research practices. However, Asia-Pacific and some countries in RoW region are expected to show lucrative growth in the upcoming period, owing to enhanced awareness about cancer and growing research practices.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2668

The market of Non-Hodgkin’s lymphomas (NHL) is driven by many promoting forces, such as, rising prevalence of Non-Hodgkin’s lymphomas (NHL) and other types of cancer, extensive R&D practices, rising concern of the population towards effects of Non-Hodgkin’s lymphomas (NHL) and rise in medical and healthcare expenditure and infrastructure. Rising prevalence of Non-Hodgkin’s lymphomas (NHL) is one of the most important market drivers. According to American Cancer Society’s recent estimations, around 71,000 new patients are diagnosed with Non-Hodgkin’s lymphomas (NHL) in 2014, and the number of deaths is expected to be around 19,000 in 2014.

Furthermore, extensive R&D practices is another important market growth factor of this market. As of now, large number of pharmaceutical companies engaged in R&D practices in order to develop innovative formulations. For instance, Rituximab SC (Roche, Inc.) is under phase III studies. On the contrary, high cost of R&D and treatment and chronic side effects are the biggest hurdles in the market growth.

Some of the key players operating in Non-Hodgkin’s Lymphoma (NHL) Therapeutics market and engaged in the development of new formulations for Non-Hodgkin’s lymphomas (NHL) include F. Hoffmann LA Roche, Inc., Amgen, Inc. ,Eli Lilly and Company, Novartis International AG, Bayer AG, Pharmacyclics, Inc., Nordic Nanovector A/S, AbbVie, Inc. and many others.

Obtain Report Details @ https://www.transparencymarketresearch.com/non-hodgkins-lymphoma-therapeutics.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non Hodgkins Lymphoma (NHL) Therapeutics Market Share and Growth Factors Impact Analysis 2014 – 2020 here

News-ID: 977995 • Views: 164

More Releases from Transparency Market Research

Molecule-based Transistors Market to Receive Overwhelming Hike in Revenues By 20 …
Molecule-based Transistors: Introduction Molecule-based transistors are single molecule electronic devices that are designed for applications such as non-volatile memory, logic circuits, sensor monitoring, and artificial synapse. Molecular transistors based on quantum interference greatly help in miniaturizing the size of electronic circuits, and in lowering heat dissipation and energy consumption in ICs. Also, organic materials have the potential to provide the electronic devices with flexibility, stretchability, and softness ("soft electronics"), which is not possible
Hydraulic Cutters Market in 2022 - Detailed Analysis Report on Latest Trends and …
Global Hydraulic Cutters Market - Introduction Hydraulic cutters work on the basic principle of hydraulic mechanism, where pressure is applied on the liquid (generally oil) to move the blades of the cutter. Force which is applied on fluids transforms the fluid and provides mechanical energy to cutters to cut the hardest material. A force is transmitted equally in all directions, with the force acting at right angles to any surface which
Hopper Loader Market Current Insight with Future Aspect Analysis 2022 - 2030 | T …
Hopper Loader: Introduction Hopper loaders are machines used to transfer any kind of material or plastic resins such as plastic regrind, plastic powders, and plastic pellets. Hopper loader comprises an integral motor that generates vacuum to deliver plastic resin material from a bulk container to a blender bin or a drying hopper. The hopper loader machine provides automatic loading without human intervention for regrind & virgin material. The material loading is accomplished
Gigabit Wi Fi Access Point Market Segmentation, Opportunities, Trends & Future S …
Gigabit Wi Fi Access Point Market: Snapshot The global gigabit Wi Fi Access market is expected to witness significant growth in the coming years on account of the rising demand for reliable and fast internet connectivity across all residential and commercial sectors. Gigabit wireless is a wireless communication system wherein data transfer speeds exceed or reach one billion bits or one gigabyte. The report offers an elaborate analysis of the market and

All 5 Releases


More Releases for NHL

Natural Hydraulic Lime (NHL) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Natural Hydraulic Lime (NHL) market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Natural Hydraulic Lime (NHL)market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Natural Hydraulic Lime (NHL)market, market definition,
Non-Hodgkin Lymphoma (NHL) Market Will Hit At CAGR of 8% Between 2012-2023.
Latest industry research report on: Non-Hodgkin Lymphoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts DelveInsights Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023-7MM Reports provides an overview of the disease and global market size of the Non-Hodgkin Lymphoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the diagnosed cases
Global Off-highway Dump Truck Market 2017 : Bell, Liebherr, Freightliner, NHL, B …
Global Off-highway Dump Truck market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Caterpillar Terex Komatsu Hitachi Construction Machinery John Deere Doosan Belaz Volvo Hydrema The survey report by Market Research Store is an overview of the global Off-highway Dump Truck market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Off-highway Dump Truck market trends
OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) – Opportunity Analy …
ReportBazzar has announced a new report titled “OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) – Opportunity Analysis And Forecasts To 2024” to their offerings. Browse report summery with TOC: http://www.reportbazzar.com/product/opportunityanalyzer-b-cell-non-hodgkins-lymphoma-nhl-opportunity-analysis-and-forecasts-to-2024/ Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. NHLs are further categorized into indolent or aggressive
OpportunityAnalyzer: B-Cell Non-Hodgkins Lymphoma (NHL) - Opportunity Analysis a …
Researchmoz added Most up-to-date research on "OpportunityAnalyzer: B-Cell Non-Hodgkins Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024" to its huge collection of research reports. Non-Hodgkins lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. NHLs are further categorized into indolent or aggressive prognostic
04-03-2008 | Sports
TICKETFINDER.com
Sale of 2008 NHL Stanley Cup Playoffs Tickets Announced by TICKETFINDER.com™
Online tickets vendor TICKETFINDER.com™ (ticketfinder.com) has recently announced the immediate sale & delivery of tickets to the 2008 Stanley Cup Playoffs due to begin on April 09, 2008. Tickets for the mega event can be purchased by visiting – http://www.ticketfinder.com/sports/hockey/nhl_hockey/#tickets TICKETFINDER.com™'s Stanley Cup tickets can be ordered online, which is the most inexpensive way to order or with an additional 10% fee via telephone on 1-800-523-1515. All tickets are priced according